Janiczek Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$27.6K Hold
299
0.01% 502
2024
Q1
$28.6K Hold
299
0.01% 505
2023
Q4
$22.8K Sell
299
-283
-49% -$19.7K 0.01% 522
2023
Q3
$40.3K Buy
582
+303
+109% +$24.3K 0.01% 392
2023
Q2
$26.3K Hold
279
0.01% 416
2023
Q1
$23.5K Hold
279
0.01% 425
2022
Q4
$21.7K Sell
279
-4
-1% -$308 0.01% 445
2022
Q3
$23K Hold
283
0.01% 430
2022
Q2
$28K Hold
283
0.01% 413
2022
Q1
$33K Buy
283
+125
+79% +$14K 0.01% 372
2021
Q4
$20K Hold
158
0.01% 480
2021
Q3
$18K Buy
158
+5
+3% +$571 0.01% 474
2021
Q2
$16K Sell
153
-210
-58% -$19.8K 0.01% 471
2021
Q1
$30K Hold
363
0.01% 327
2020
Q4
$33K Sell
363
-7
-2% -$581 0.02% 264
2020
Q3
$30K Buy
370
+19
+5% +$1.48K 0.02% 126
2020
Q2
$24K Buy
351
+141
+67% +$10K 0.01% 110
2020
Q1
$13K Hold
210
0.01% 97
2019
Q4
$16K Hold
210
0.01% 99
2019
Q3
$15K Buy
210
+90
+75% +$6.32K 0.01% 102
2019
Q2
$7K Buy
+120
New +$7.26K ﹤0.01% 142

Other funds holding EW

Janiczek Wealth Management's EW Position: Q2 2024 in Review

Janiczek Wealth Management held its Edwards Lifesciences (EW) position steady in Q2 2024 at 299 shares worth $27.6K. The position accounts for 0.01% of the portfolio, ranked #502.

Janiczek Wealth Management first reported a position in EW in Q2 2019 and has held it in 21 quarters since. The position peaked at $40.3K in Q3 2023. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Janiczek Wealth Management held 299 shares of Edwards Lifesciences worth $27.6K as of Q2 2024.
  • Janiczek Wealth Management left its Edwards Lifesciences share count unchanged in Q2 2024.
  • Edwards Lifesciences made up 0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #502 holding.
  • Janiczek Wealth Management first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 21 quarters since.
  • Janiczek Wealth Management's Edwards Lifesciences position peaked at $40.3K in Q3 2023.
  • 1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.